Advanced Search

 

Study ID Status Title Patient Level Data
IDB-707-110 Completed Clinical Study to Evaluate Safety, Tolerance and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2006 – 2007 Season) in Adults Aged Between 18-60 and over 60
ILI105618 Completed A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 (SB-485232) Administered by Intravenous Infusion in Combinationwith Rituximab in Adult Patients with B Cell Non-Hodgkin'sLymphoma" Study Listed on ClinicalStudyDataRequest.com
ILI108621 Completed A phase I, dose escalation study to assess the safety & biological activity of Interleukin 18 (SB-485232) administered by IV infusion in combination with pegylated liposomal doxorubicin (Doxil) in advanced stage epithelial ovarian cancer Study Listed on ClinicalStudyDataRequest.com
IMU40001 Completed A randomised, single-dose, three-way cross-over study evaluating the bioequivalence of 50 mg oral doses of the azathioprine formulation manufactured in Germany compared to the azathioprine formulations manufactured in France and UK in healthy volunteers.
IND/SEREACC/PMS Completed Post Marketing Surveillance (PMS) of salmeterol and fluticasone in fixed dose combination (Seretide® Accuhaler) in the Treatment of Bronchial Asthma.
India Flixonase PMS (no study number) Completed Title Post Marketing Surveillance of Flixonase (Fluticasone Propionate Aqueous Nasal Spray (FPANS)) to Evaluate the Safety of Fluticasone 200 micrograms (mcg) Nasal Spray in Indian Patients with Allergic Rhinitis
ING111207 Completed A Double-Blind, Randomized, Placebo-Controlled, Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1349572 in Healthy Subjects
ING111322 Completed GSK1349572 Repeat Dose Escalation Study
INO102141 Completed A two-centre, randomised, double-blind, double-dummy, placebo-controlled, 3-period cross-over study to evaluate the effect of treatment with repeat doses of GW274150 on the allergen-induced late asthmatic response in subjects with mild asthma.
INT 2767 Completed Interaction Study of 975mg Aspirin Given at Steady State of 10mg/sc SR90107A/Org31540 in Healthy Male Subjects
INT 3012 Completed Influence of Forced Diuresis on the Pharmacokinetics of Org31540/SR90107 After a Single Dose of 10 mg s.c. of Org31540/SR90107A in Healthy Male Subjects
INT3933 Completed Assessment of pharmacokinetic and pharmacodynamic drug interactions between ORG31540/SR90107A and digoxin in healthy male subjects
INT-CAR-13 Completed Effect of carvedilol as compared to an ACE-inhibitor (enalapril) on hypertension and “quality of life” related well-being.
IP2107882 Completed A single-centre, randomized, double-blind , placebo controlled, dose escalating cross-over study to evaluate the safety, tolerability and pharmacokinetics of single inhaled doses of GSK610677 and placebo in healthy male subjects
IPA101985 Completed A two-centre, randomised, double-blind, placebo-controlled, 2-period cross-over study to evaluate the effect of treatment with repeat doses of inhaled GSK256066 on the allergen-induced late asthmatic response in subjects with mild asthma
IPC101939 Completed A randomised, double-blind, placebo-controlled study to investigate the safety and tolerability of inhaled GSK256066 in mild to moderate COPD patients
IPC103711 Completed A double blind, placebo controlled, repeat dose study to compare the effectiveness of two doses of GSK256066 with placebo in reducing lung inflammation following segmental LPS challenge in healthy volunteers
IPR101987 Completed A 14 day, randomised, double blinded, placebo-controlled 2-way crossover trial of repeat doses of intranasal GSK256066 and placebo in an environmental exposition unit (Vienna Challenge Chamber) in subjects with seasonal allergic rhinitis (SAR)
IPR107498 Completed An 8 day, randomised, double blinded, placebo-controlled 2-way crossover trial of repeat doses of intranasal GSK256066 and placebo in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR)
IPR109764 Completed A randomised, open, placebo-controlled 5-way crossover trial of single doses of intranasal GSK256066 in subjects with seasonal allergic rhinitis (SAR).
IPR110723 Completed An 8 day, randomised, double blind, 3-way crossover trial of repeat doses of intranasal GSK256066 and fluticasone propionate in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
IPR110982 Completed A randomised, double blind, 2-way crossover trial of 8 days repeat dosing with intranasal GSK256066 and azelastine hydrochloride in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR)
ISO105774 Completed Single-blind, placebo-controlled, randomized study testing single ascending doses of GSK369796 in healthy subjects
ITI101711 Completed A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism following Total Knee Replacement Surgery
ITZ111682 Completed A Single Dose, Randomized Study to Assess the Relative Bioavailability of Two Formulations and Food Effect on GSK1265744 in Healthy Male and Female Subjects

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.